New treatment options allow patients with chronic lymphocytic leukemia (CLL) to live longer than they used to with the former standard of care, chlorambucil-based chemotherapy. Clinical trials are underway for a variety of options:
- Chemo-immunotherapy
- Monoclonal antibodies that enhance the immune system
- Small molecule targeted therapies that take advantage of specific weaknesses in cancer cells.
Through clinical trials, doctors are able to carefully study and learn which new regimens are better at treating CLL. They're also one of the best ways for patients to get state-of-the-art cancer treatment. You can find out if you're eligible for a clinical trial by talking with your doctor or checking ClinicalTrials.gov.
Read More